Replies to post #37311 on Intellipharmaceutics International Inc. (IPCI)

[doogdilinger]

Yep on track to book less than $2M in revenue for fiscal year 2018 from ongoing sales of FocalinXR and SeroquelXR. They would've been way better off just selling both ANDA's outright at this point and at least getting a decent chunk of cash and then using those monies to avoid the oncoming dilution